Rohit Malpani, director of policy and advocacy at Doctors Without Borders/Médecins Sans Frontières (MSF)'s Access Campaign, provided witness testimony on June 27, 2013, during a U.S. Congressional hearing on India's trade policies.

More >

MSF International President, Dr. Unni Karunakara, in his keynote speech at the 2012 Universities Allied for Essential Medicines conference:

More >

An open letter to Joe Jiminez and Daniel Vassella, the CEO and President of Novartis, respectively. 

More >

I am writing on behalf of MSF to express our disappointment that J&J has not yet placed any patent into the Medicines Patent Pool and that it has announced in a recent letter to the Medicines Patent Pool that it is not ready to engage in formal negotiations.

More >

MSF testified at a hearing before the US Trade Representative about the effect of US trade and intellectual property pressures on global health policy and efforts to expand access to affordable medicines in developing countries.

More >